Agency for Healthcare Research and Quality September 5, 2023 – Federal Register Recent Federal Regulation Documents
Results 1 - 2 of 2
Supplemental Evidence and Data Request on Treatment of Stage I-III Squamous Cell Anal Cancer
The Agency for Healthcare Research and Quality (AHRQ) is seeking scientific information submissions from the public. Scientific information is being solicited to inform our review on Treatment of Stage I-III Squamous Cell Anal Cancer, which is currently being conducted by the AHRQ's Evidence-based Practice Centers (EPC) Program. Access to published and unpublished pertinent scientific information will improve the quality of this review.
Agency Information Collection Activities: Proposed Collection; Comment Request
This notice announces the intention of the Agency for Healthcare Research and Quality (AHRQ) to request that the Office of Management and Budget (OMB) approve the proposed information collection project ``Use of Open-Ended Responses to Explore Disparities in Patient Experience.'' This proposed information collection was previously published in the Federal Register on June 27th, 2023, and allowed 60 days for public comment. AHRQ received no substantive comments from members of the public. The purpose of this notice is to allow an additional 30 days for public comment.
This site is protected by reCAPTCHA and the Google
Privacy Policy and
Terms of Service apply.
